CD44 and hepatocellular carcinoma: After adjustment for the four risk factors, a higher risk of HCC was experienced by carriers of the CD44 rs13347 heterozygous variant (CT; OR = 1.626, 95% CI = 1.057‐2.500, P = .027), the homozygote variant (TT) genotype (OR = 1.965, 95% CI = 1.043‐3.702, P = .037), and the T allele (OR = 1.461, 95% CI = 1.091‐1.956, P = .011) when compared to the healthy controls.